Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Labema is a Finnish life science and biotechnology distribution company focused on diagnostic equipment, laboratory consumables, and related services for healthcare, food industry, and research laboratories. Founded in 1988, the company operates primarily in microbiology, molecular biology, clinical diagnostics, food diagnostics, drug of abuse diagnostics, and selected research workflows. Labema does not appear to be a therapeutic drug developer; instead, it commercializes third-party instruments, assays, and laboratory products and supports customers with scientific and technical expertise. The company has operations in Finland and the Baltics and has highlighted supplier relationships across diagnostic and laboratory tools companies. Labema was acquired by Indutrade in 2023 and appears to continue operating as an active subsidiary or operating company within the Indutrade group.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Labema.